Currently, guidelines recommend prasugrel as an initial P2Y12 inhibitor over clopidogrel, unless the patients are older than 75 years of age, have low body weight (<60 kg), or previous history of transient ischemic attack or stroke [4]. Here, P2RY12 is linked to Stroke.